BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Pain Therapeutics Inc.

About Pain Therapeutics Inc.

Pain Therapeutics is a biopharmaceutical company that develops novel drugs.

Their drugs target severe chronic pain, such as pain associated with advanced osteoarthritis, low-back pain or irritable bowel syndrome.

Pain Therapeutics has three proprietary drug candidates in clinical development: Oxytrex™, Remoxy™ and PTI-901. Pain Therapeutics believe the target market for these three drug candidates exceeds $3 billion per year.

 

PIPELINE

 

OXYTREX -- treat severe chronic pain, such as low back, osteoarthritic pain or cancer pain

REMOXY --is a proprietary abuse-resistant version of time-release oxycodone

PTI-901 --treats chronic Irritable Bowel Syndrome (IBS). PTI-901 is a proprietary drug candidate that consists of an oral low-dose opioid antagonist

 

 

More About Pain Therapeutics

Home Page

Key Statistics for Pain Therapeutics

Basic Chart for Pain Therapeutics

Analyst Opinion

Analysts Estimates

NEWS

 
Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright © 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com